Suppr超能文献

硝苯地平与酚妥拉明治疗早产的随机多中心临床研究。

Nifedipine versus fenoterol in the management of preterm labor: a randomized, multicenter clinical study.

机构信息

Unidad de Medicina Materno Fetal, Hospital Clínico Universidad de Chile, Santiago de Chile, Chile.

出版信息

Gynecol Obstet Invest. 2012;74(2):109-15. doi: 10.1159/000338856. Epub 2012 Jul 10.

Abstract

PURPOSE

To compare the efficacy of nifedipine and fenoterol in the management of threatened preterm labor (TPL).

METHODS

A randomized and multicenter study assessing the tocolytic effect of nifedipine versus fenoterol in patients admitted to the participating maternity units with a diagnosis of TPL and a cost-savings study for economic assessment. For a power of 80% and an α error equal to 0.05, 132 consecutive patients were recruited during the study period; 66 patients were assigned to each group. A χ(2) analysis and a mean differences test were performed according to variable types and survival curves per intention-to-treat.

RESULTS

Demographics were similar in both groups. The latency period was similar in both groups (26.7 vs. 25.6; p = 0.3). There were no differences in the results obtained. Nifedipine failed more frequently to obtain tocolysis when used as a first-line agent (80 vs. 90%, p = 0.0001). The group treated with fenoterol showed more drug adverse events (57.8 vs. 19.0%, p = 0.0001). The economic assessment did not evidence a significant difference in terms of cost savings between groups treated with either drug.

CONCLUSION

The present study failed to demonstrate either clinical or economic superiority of any of the two drugs used in TPL management. The highest failure percentage of nifedipine when used as a first-line agent should encourage further research.

摘要

目的

比较硝苯地平和非诺特罗在治疗早产先兆(TPL)中的疗效。

方法

这是一项随机、多中心研究,评估硝苯地平与非诺特罗在诊断为 TPL 并入住参与产科单位的患者中的保胎效果,并进行了一项经济评估的成本节约研究。在研究期间,为了达到 80%的效力和 0.05 的α错误,共招募了 132 名连续患者;每组 66 名患者。根据变量类型和按意向治疗的生存曲线进行 χ²分析和均值差异检验。

结果

两组患者的人口统计学特征相似。潜伏期在两组间相似(26.7 对 25.6;p=0.3)。结果无差异。硝苯地平作为一线药物时,更频繁地无法达到保胎效果(80%对 90%,p=0.0001)。使用非诺特罗治疗的组出现更多药物不良反应(57.8%对 19.0%,p=0.0001)。经济评估未发现两组药物治疗的成本节约方面存在显著差异。

结论

本研究未能证明 TPL 管理中使用的两种药物中的任何一种在临床或经济方面具有优势。硝苯地平作为一线药物时的最高失败百分比应鼓励进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验